Skip to main content
    A

    Amicus Therapeutics Inc (FOLD)

    Official site

    BIOTECHNOLOGY

    $14.49
    +0.00 (+0.00%)

    Last updated: Apr 27, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    38%(14/37)
    Avg Surprise
    -8.67%
    Streak
    4 Q

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$0.02
    Range$0.02 - $0.02
    1 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.15-89.6%
    60d ago$0.15-89.6%
    30d ago$0.15-89.6%
    7d ago$0.15-89.6%
    Current$0.02
    Revenue Consensus
    $181M
    Range$178M - $185M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26EST
    		-$0.02---
    Dec 25
    Reported Feb 19
    		$0.10$0.07+53.85%Beat+11.1%
    Sep 25
    Reported Nov 4
    		$0.06$0.03+100.00%Beat+400.0%
    Jun 25
    Reported Jul 31
    		$-0.08$-0.11+27.27%Beat-60.0%
    Mar 25
    Reported May 7
    		$0.03N/A+142.86%Beat+118.8%
    Dec 24
    Reported Feb 26
    		$0.09$0.09-1.21%Miss+181.8%
    Sep 24
    Reported Nov 6
    		$-0.02$-0.01-100.00%Miss+71.4%
    Jun 24
    Reported Aug 8
    		$-0.05$-0.06+16.67%Beat+66.7%
    Mar 24
    Reported May 9
    		$-0.16$-0.07-128.57%Miss+11.1%
    Dec 23
    Reported Feb 28
    		$-0.11$-0.06-83.33%Miss+42.1%
    Sep 23
    Reported Nov 8
    		$-0.07$-0.08+12.50%Beat+41.7%
    Jun 23
    Reported Aug 8
    		$-0.15$-0.12-25.00%Miss+28.6%
    Mar 23
    Reported May 10
    		$-0.18$-0.15-20.00%Miss+40.0%
    Dec 22
    Reported Mar 1
    		$-0.19$-0.13-46.15%Miss+34.5%
    Sep 22
    Reported Nov 7
    		$-0.12$-0.19+36.84%Beat+36.8%
    Jun 22
    Reported Aug 4
    		$-0.21$-0.22+4.55%Beat-10.5%
    Mar 22
    Reported May 9
    		$-0.30$-0.25-20.00%Miss-20.0%
    Dec 21
    Reported Feb 24
    		$-0.29$-0.16-81.25%Miss-7.4%
    Sep 21
    Reported Nov 9
    		$-0.19$-0.17-11.76%Miss+17.4%
    Jun 21
    Reported Aug 5
    		$-0.19$-0.21+9.52%Beat+5.0%
    Mar 21
    Reported May 10
    		$-0.25$-0.23-8.70%Miss+26.5%
    Dec 20
    Reported Mar 1
    		$-0.27$-0.22-22.73%Miss+22.9%
    Sep 20
    Reported Nov 5
    		$-0.23$-0.22-4.55%Miss+4.2%
    Jun 20
    Reported Aug 10
    		$-0.20$-0.26+23.08%Beat+44.4%
    Mar 20
    Reported May 7
    		$-0.34$-0.28-21.43%Miss+12.8%
    Dec 19
    Reported Mar 2
    		$-0.35$-0.27-29.63%Miss+14.6%
    Sep 19
    Reported Nov 11
    		$-0.24$-0.32+25.00%Beat+22.6%
    Jun 19
    Reported Aug 8
    		$-0.36$-0.33-9.09%Miss-9.1%
    Mar 19
    Reported May 8
    		$-0.39$-0.31-25.81%Miss-39.3%
    Dec 18
    Reported Feb 28
    		$-0.41$-0.28-46.43%Miss+0.0%
    Sep 18
    Reported Nov 5
    		$-0.31$-0.28-10.71%Miss+24.4%
    Jun 18
    Reported Aug 7
    		$-0.33$-0.33+0.00%Beat+2.9%
    Mar 18
    Reported May 8
    		$-0.28$-0.36+22.22%Beat+28.2%
    Dec 17
    Reported Feb 28
    		$-0.41$-0.30-36.67%Miss+2.4%
    Sep 17
    Reported Nov 8
    		$-0.41$-0.31-32.26%Miss-
    Jun 17
    Reported Aug 7
    		$-0.34$-0.36+5.56%Beat-
    Mar 17
    Reported May 9
    		$-0.39$-0.36-8.33%Miss-
    Dec 16
    Reported Mar 1
    		$-0.42$-0.33-27.27%Miss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$14.46
    SMA 20$14.46
    SMA 50$14.40
    SMA 200$10.88
    EMA 10$14.47
    EMA 20$14.45
    EMA 50$14.26
    EMA 200$11.67

    MACD

    Line: 0.03Signal: 0.03Hist: -0.00

    ADX

    ADX: 68.6+DI: 31.3-DI: 4.0

    Aroon & PSAR

    Aroon Up96.0
    Aroon DownN/A
    PSAR$14.45

    Bollinger Bands

    Upper Band$14.49
    Lower Band$14.43
    %B Position40%(Middle)
    Band Width1.03

    RSI (14-Day)

    Overbought
    72.1

    Momentum Oscillators

    Stoch %K73.3
    Stoch %D66.7
    Williams %R-20.0
    ROC (10d)0.2%
    Momentum0.03
    CCI (20d)197.2
    MFI (14d)46.2

    Volatility Measures

    ATR (14d)$0.02(0.1%)
    StdDev (20d)0.01
    Hist Vol1.4%(Low)

    Volume Flow

    VWAP$14.49
    OBV291.4M
    AD Line-130.6M
    CMF (20d)0.100

    Volume Metrics

    Avg Vol (20d)2.7M
    Vol RatioN/A
    VWMA (20d)$14.46

    Pivot Points

    R3$14.51
    R2$14.50
    R1$14.50
    Pivot Point$14.49
    S1$14.49
    S2$14.48
    S3$14.48

    Advanced Oscillators

    TSI34.31
    Ultimate Osc55.0
    KST4.95

    Financial Data

    QuarterDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Total Revenue$185.21M$169.06M$154.69M$125.25M$149.71M$141.52M$126.67M$110.40M$115.08M$103.50M$94.50M$86.27M
    Cost of Revenue$26.55M$19.47M$15.22M$11.70M$14.84M$13.28M$11.26M$13.57M$11.32M$9.95M$9.11M$6.94M
    Gross Profit$158.66M$149.59M$139.47M$113.55M$134.87M$128.24M$115.41M$96.84M$103.76M$93.56M$85.39M$79.33M
    Operating Expenses$142.72M$115.33M$148.94M$121.50M$118.90M$106.58M$100.44M$124.56M$107.70M$110.58M$104.25M$116.71M
    R&D$23.74M$23.41M$60.85M$27.84M$30.19M$26.16M$24.68M$28.33M$35.03M$40.70M$35.15M$41.50M
    SG&A$117.08M$90.04M$84.54M$91.83M$86.67M$75.11M$73.58M$88.03M$70.24M$65.65M$65.42M$73.96M
    Operating Income$15.95M$34.27M$-9,474,000$-7,952,000$15.97M$21.66M$14.97M$-27,721,000$-3,692,000$-17,023,000$-18,860,000$-37,636,000
    Interest Income$833,000$829,000$843,000$812,000$1.42M$1.08M$1.37M$1.54M$1.67M$1.47M$1.74M$2.20M
    Interest Expense$11.43M$11.71M$11.56M$11.46M$11.96M$12.69M$12.51M$12.44M$26.76M$12.99M$12.49M$11.84M
    Income Before Tax$3.14M$34.27M$-19,181,000$-18,045,000$7.93M$6.79M$108,000$-43,583,000$-31,660,000$-24,705,000$-40,517,000$-53,219,000
    Income Tax Expense$1.45M$16.97M$5.24M$3.64M$-6,805,000$13.51M$15.80M$4.84M$2.18M$-3,128,000$2.71M$-287,000
    Net Income$1.69M$17.31M$-24,420,000$-21,686,000$14.74M$-6,729,000$-15,697,000$-48,419,000$-33,843,000$-21,577,000$-43,232,000$-52,932,000
    EBITDA$16.31M$47.69M$-5,977,000$-4,959,000$21.11M$21.14M$13.99M$-30,002,000$-3,602,000$-10,241,000$-26,864,000$-41,901,000
    EBIT$13.74M$45.16M$-8,459,000$-7,402,000$18.48M$18.40M$11.25M$-32,687,000$-6,320,000$-13,190,000$-29,762,000$-43,825,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about FOLD

    FOLD Competitors

    CompanyTicker
    Option Care Health IncOPCH
    Akero Therapeutics IncAKRO
    Lifestance Health Group IncLFST
    Diversified Healthcare TrustDHCNL
    Concentra Group Holdings Parent, Inc.CON
    Integer Holdings CorpITGR
    Scholar Rock Holding CorpSRRK
    Heartflow, Inc. Common StockHTFL

    Sector: Healthcare

    FOLD Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    13.9%
    EPS estimate (fiscal period ending Jun 30, 2026)
    $0.02
    Estimate revisions (30 days, fiscal period ending Jun 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About FOLD

    Does FOLD pay dividends?

    Amicus Therapeutics Inc (FOLD) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with F

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In